vorinostat has been researched along with Pregnancy in 12 studies
Vorinostat: A hydroxamic acid and anilide derivative that acts as a HISTONE DEACETYLASE inhibitor. It is used in the treatment of CUTANEOUS T-CELL LYMPHOMA and SEZARY SYNDROME.
vorinostat : A dicarboxylic acid diamide comprising suberic (octanedioic) acid coupled to aniline and hydroxylamine. A histone deacetylase inhibitor, it is marketed under the name Zolinza for the treatment of cutaneous T cell lymphoma (CTCL).
Pregnancy: The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH.
Excerpt | Relevance | Reference |
---|---|---|
"Depression is a disabling psychiatric disorder affecting millions of people all around the world." | 1.62 | SAHA Improves Depressive Symptoms, Cognitive Impairment and Oxidative Stress: Rise of a New Antidepressant Class. ( Amini-Khoei, H; Dehpour, AR; Ershadi, ASB; Hosseini, MJ, 2021) |
"Sevoflurane is a widely used volatile anesthetic in clinical practice." | 1.51 | Suberoylanilide hydroxamic acid (SAHA) alleviates the learning and memory impairment in rat offspring caused by maternal sevoflurane exposure during late gestation. ( Feng, N; Hu, Y; Li, M; Liu, Y; Liu, Z; Luo, F; Wu, L; Xu, L; Yu, Q; Zhao, W, 2019) |
"SAHA and TSA could inhibit total HDAC activity and placental HDAC1/2/3 expression both in Bewo and JAR, but displayed a transient induction of HDAC mRNA or protein level after being treated at low dosage or prolonged exposure to drugs." | 1.46 | The effect of histone deacetylase inhibition on the expression of P-glycoprotein in human placental trophoblast cell lines. ( Duan, H; Hua, Y; Li, Q; Li, Y; Qiu, D; Wang, C; Wang, T; Zhang, Y; Zhou, K, 2017) |
" Our previous studies have demonstrated the social cognition deficits observed in this model, a major core symptom of ASD, to be ameliorated following chronic administration of histone deacetylase (HDAC) inhibitors." | 1.40 | Pentyl-4-yn-VPA, a histone deacetylase inhibitor, ameliorates deficits in social behavior and cognition in a rodent model of autism spectrum disorders. ( Cassidy, AW; Foley, AG; Regan, CM, 2014) |
"Animals were dosed on Gestation Days 6-20 or 7-20, respectively, with litter/fetal parameters evaluated on GD 21 and 28, respectively." | 1.34 | Assessment of developmental toxicity of vorinostat, a histone deacetylase inhibitor, in Sprague-Dawley rats and Dutch Belted rabbits. ( Kerr, JS; Turner, KJ; Wise, LD, 2007) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (16.67) | 29.6817 |
2010's | 8 (66.67) | 24.3611 |
2020's | 2 (16.67) | 2.80 |
Authors | Studies |
---|---|
Song, XY | 1 |
Liu, XW | 1 |
Wang, J | 1 |
Ershadi, ASB | 1 |
Amini-Khoei, H | 1 |
Hosseini, MJ | 1 |
Dehpour, AR | 1 |
Jin, L | 1 |
Guo, Q | 1 |
Zhu, HY | 1 |
Xing, XX | 1 |
Zhang, GL | 1 |
Xuan, MF | 1 |
Luo, QR | 1 |
Luo, ZB | 1 |
Wang, JX | 1 |
Choe, HM | 1 |
Paek, HJ | 1 |
Yin, XJ | 1 |
Kang, JD | 1 |
Lin, J | 1 |
Wang, S | 1 |
Feng, Y | 1 |
Zhao, W | 4 |
Luo, F | 2 |
Feng, N | 2 |
Melchior, M | 1 |
Juif, PE | 1 |
Gazzo, G | 1 |
Petit-Demoulière, N | 1 |
Chavant, V | 1 |
Lacaud, A | 1 |
Goumon, Y | 1 |
Charlet, A | 1 |
Lelièvre, V | 1 |
Poisbeau, P | 1 |
Yu, Q | 1 |
Hu, Y | 1 |
Liu, Z | 1 |
Li, M | 1 |
Xu, L | 1 |
Wu, L | 1 |
Liu, Y | 1 |
Foley, AG | 1 |
Cassidy, AW | 1 |
Regan, CM | 1 |
Kim, MJ | 1 |
Oh, HJ | 1 |
Kim, GA | 1 |
Suh, HN | 1 |
Jo, YK | 1 |
Choi, YB | 1 |
Kim, DH | 1 |
Han, HJ | 1 |
Lee, BC | 1 |
Duan, H | 1 |
Wang, C | 1 |
Zhou, K | 1 |
Wang, T | 1 |
Li, Y | 1 |
Qiu, D | 1 |
Li, Q | 1 |
Zhang, Y | 1 |
Hua, Y | 1 |
Chen, SH | 1 |
Wu, HM | 1 |
Ossola, B | 1 |
Schendzielorz, N | 1 |
Wilson, BC | 1 |
Chu, CH | 1 |
Chen, SL | 1 |
Wang, Q | 1 |
Zhang, D | 1 |
Qian, L | 1 |
Li, X | 1 |
Hong, JS | 1 |
Lu, RB | 1 |
Wise, LD | 1 |
Turner, KJ | 1 |
Kerr, JS | 1 |
Giavini, E | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
A 12-weeks, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety and Related Mechanism of Sulforaphane in Treatment of Autism Spectrum Disorder[NCT02879110] | 110 participants (Actual) | Interventional | 2016-08-31 | Completed | |||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
12 other studies available for vorinostat and Pregnancy
Article | Year |
---|---|
Suberoylanilide hydroxamic acid (SAHA) attenuates memory impairment in the offspring of rats exposed to sevoflurane anesthesia.
Topics: Anesthesia; Animals; Female; Hippocampus; Learning; Memory Disorders; MicroRNAs; Pregnancy; Rats; Se | 2023 |
SAHA Improves Depressive Symptoms, Cognitive Impairment and Oxidative Stress: Rise of a New Antidepressant Class.
Topics: Animals; Antidepressive Agents; Behavior, Animal; Cognitive Dysfunction; Depression; Female; Fluoxet | 2021 |
Histone deacetylase inhibitor M344 significantly improves nuclear reprogramming, blastocyst quality, and in vitro developmental capacity of cloned pig embryos.
Topics: Acetylation; Animals; Blastocyst; Cellular Reprogramming; Embryo, Mammalian; Embryonic Development; | 2017 |
Propofol exposure during early gestation impairs learning and memory in rat offspring by inhibiting the acetylation of histone.
Topics: Acetylation; Anesthesia; Animals; Cyclic AMP Response Element-Binding Protein; Down-Regulation; Drug | 2018 |
Pharmacological rescue of nociceptive hypersensitivity and oxytocin analgesia impairment in a rat model of neonatal maternal separation.
Topics: Action Potentials; Analgesics; Animals; Animals, Newborn; Antidiuretic Hormone Receptor Antagonists; | 2018 |
Suberoylanilide hydroxamic acid (SAHA) alleviates the learning and memory impairment in rat offspring caused by maternal sevoflurane exposure during late gestation.
Topics: Anesthetics, Inhalation; Animals; Cyclic AMP Response Element-Binding Protein; Female; Hippocampus; | 2019 |
Pentyl-4-yn-VPA, a histone deacetylase inhibitor, ameliorates deficits in social behavior and cognition in a rodent model of autism spectrum disorders.
Topics: Acetylation; Animals; Behavior, Animal; Cerebellar Cortex; Child Development Disorders, Pervasive; C | 2014 |
Altering histone acetylation status in donor cells with suberoylanilide hydroxamic acid does not affect dog cloning efficiency.
Topics: Acetylation; Animals; Apoptosis; Cellular Reprogramming; Cloning, Organism; Dogs; Dose-Response Rela | 2015 |
The effect of histone deacetylase inhibition on the expression of P-glycoprotein in human placental trophoblast cell lines.
Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Line; Female; Histone Deacetylase Inhi | 2017 |
Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor, protects dopaminergic neurons from neurotoxin-induced damage.
Topics: 1-Methyl-4-phenylpyridinium; Animals; Animals, Newborn; Astrocytes; Cell Survival; Cells, Cultured; | 2012 |
Assessment of developmental toxicity of vorinostat, a histone deacetylase inhibitor, in Sprague-Dawley rats and Dutch Belted rabbits.
Topics: Abnormalities, Drug-Induced; Animals; Body Weight; Dose-Response Relationship, Drug; Enzyme Inhibito | 2007 |
Comment on developmental toxicity evaluation on Vorinostat and relationship with HDAC inhibition.
Topics: Abnormalities, Drug-Induced; Animals; Bone Development; Enzyme Inhibitors; Female; Fetal Development | 2007 |